all stories

HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES

One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Mon, 19 October 2026

What it is about

Prnewswire HistoindexTechnology OrganisationBiomedical Research CouncilTerms Of ServiceAgency For ScienceManila, Manila, PhilippinesSingaporeColorado, United StatesDenver, Colorado, United States

Who published it, and when

How it spread - 1 original report

  1. Mon, 19 October 2026

    1 report
    • manilatimes.net03:55first to report

      SINGAPORE, Oct. 19, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the preclinical evaluation and characterization of therapeutic candidates for various fibrotic diseases, including cancer-associated fibrosis.

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.